Skip to main content

Tampa General Hospital announces strategic partnership with Philips to innovate and improve patient experience


September 23, 2020
The seven-year agreement between the two organizations will upgrade technology throughout the hospital and improve efficiencyAmsterdam, the Netherlands and Tampa, Florida, U.S. – Tampa General Hospital (TGH) and Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced they are creating a long-term strategic partnership designed to keep Tampa General Hospital at the forefront of technological innovation.Tampa General, one of the largest hospitals in the U.S., will have early and ongoing access to the latest Philips innovations during the seven-year arrangement. This will allow the hospital to continue delivering world-class care while lowering costs.“We are humbled by the heroic work the TGH team is doing during the pandemic and their dedication to constantly improving care across the board, even in these difficult times,” said Vitor Rocha, Chief Philips North America, member of the Executive Committee Royal Philips. “The relationship between TGH and Philips builds on a shared drive for innovation in healthcare – to deliver on the Quadruple Aim, break down the barriers between hospital and home and improve people’s lives. For us, the partnership is more than transactional. It means taking the time to truly understand their patients’ needs and suggest solutions that can address their workflow and service line needs today, while planning for tomorrow.”Under the terms of this strategic partnership, Philips will provide the hospital with millions of dollars’ worth of new solutions such as new software packages, healthcare informatics, unique workflow solutions and high-level consulting.As a result, Tampa General will replace all bedside patient and vital sign monitors throughout the 1,006-bed hospital and upgrade key imaging equipment in the catheterization laboratories and interventional radiology rooms.Philips also plans to deliver a standardized platform, providing doctors and clinicians with a better overall view of the patient to help make the best decisions when it comes to diagnosis and providing world-class care.“This partnership allows us to stay on the leading edge of technology for many years to come, in a cost-effective way,” said TGH President and CEO John Couris. “Philips not only provides new solutions, but also serves as a valuable partner by helping us improve our workflows and optimization. Tampa General’s vision is to become the safest and most innovative academic health system in America, and long-term commitments like this one will help us achieve that vision.”The transformational partnership shows Tampa General is investing in long-term innovation. Together, Philips and Tampa General have already invested more than 1,000 hours on technology replacement planning and performed over 400 clinical staff interviews to understand how to better improve the patient and staff experience. Philips is also working on a technology replacement plan which includes implementing cloud-based technologies such as Philips PerformanceBridge. This technology gives users a view to all their diagnostic equipment and ensures that TGH gets the latest in medical innovation in a cost-effective, timely way. A key benefit for Tampa General is that Philips solutions are built to integrate with the hospital’s existing technologies for a seamless experience for clinicians and patients. For further information, please contact:Joost Maltha
Philips Global Press Office
Tel.: +31 6 10 55 81 16
E-mail: joost.maltha@philips.com
Jennifer McVan                                                                                                                                           Silvie Casanova 
Philips North America
Tel.: +1 781 879-0692
About Royal Philips

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.